When measles resurfaces in under-vaccinated communities, the clinical consequences are swift and serious — and a 2025 outbreak in West Texas provides one of the most detailed hospitalization portraits in recent U.S. epidemiological literature. The data challenge any lingering assumption that measles is a mild childhood illness in the modern era.
Between January 20 and March 18, 2025, 325 confirmed measles cases emerged in West Texas following notification of an index case in an unvaccinated school-aged child. Of those, 60 patients (18.5%) required hospitalization. Medical records were available for 54 hospitalized individuals; 90.7% were under 18 years of age, and critically, 88.9% had no underlying medical conditions — meaning severe disease was not confined to immunocompromised or otherwise vulnerable patients. Every hospitalized case was either unvaccinated or had unknown vaccination status. Pneumonia emerged as the dominant complication, affecting 72.2% of hospitalized patients, followed by dehydration in 46.3%. Supplemental oxygen was required in 70.4% of cases, four patients were admitted to intensive care, two required mechanical ventilation, and one patient died. Median hospital stay was two days, though the range extended to 20 days.
This outbreak report arrives at a moment when U.S. measles vaccination coverage has shown measurable slippage since the COVID-19 pandemic disrupted routine immunization schedules. The CDC's two-dose MMR vaccine confers approximately 97% protection, yet geographic clustering of vaccine-hesitant populations can suppress herd immunity thresholds — estimated at 95% coverage — even when national averages appear adequate. What makes this MMWR report analytically significant is its granular clinical detail: the pneumonia burden here (72.2%) exceeds the roughly 1-in-20 rate typically cited in pre-elimination-era U.S. literature, possibly reflecting the concentration of unvaccinated children in a single outbreak setting. The finding that nearly nine in ten hospitalized patients had no pre-existing conditions underscores that measles severity is an intrinsic property of the virus, not primarily a comorbidity issue. This is a confirmatory but important signal that immunity gaps carry real and immediate clinical costs.